GlassScriptPhysician profile
Huberto Perez
NPI 1679596449
$5,386.74
in general payments reported to CMS, 2019-2025
21 companies · $941 in 2025
The $941 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.33 · 2020: $99.11 · 2021: $675 · 2022: $499 · 2023: $2,327 · 2024: $803 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,331 · Travel and Lodging: $1,542 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,330.69 |
| Travel and Lodging | $1,541.94 |
| Education | $197.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,626.59 | 2023 | Iolmaster 700, Veracity Surgical, Artevo 800 |
| Alcon Vision LLC | $993.54 | 2019-2025 | Centurion, Clareon Panoptix Pro, Clareon |
| Mallinckrodt Hospital Products INC. | $655.55 | 2021-2025 | Acthar |
| Biotissue Holdings INC. | $344.42 | 2020-2025 | |
| Amgen INC. | $300.23 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $201.10 | 2020-2023 | |
| Harrow Eye, LLC | $180.74 | 2024-2025 | Vevye |
| Sight Sciences, INC. | $175.20 | 2021-2022 | |
| Abbvie INC. | $152.65 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $138.93 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $114.91 | 2021 | |
| Glaukos Corporation | $101.64 | 2020-2024 | Idose |
| Rayner Intraocular Lenses Limited | $98.73 | 2023-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $95.30 | 2022-2025 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $48.57 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $36.98 | 2025 | |
| Dompe US, INC. | $30.44 | 2025 | Oxervate |
| New World Medical,INC. | $29.16 | 2025 | Via360, Ahmed Glaucoma Valve, Clearpath |
| Rxsight INC | $21.78 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Regeneron Healthcare Solutions, INC. | $21.33 | 2022 | |
| Omeros Corporation | $18.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huberto Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.